Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p74
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 74/162)
Character Range: 15048587–15054752

the initiation of anti-hypertensive therapy; AND
                                                                                                         The condition must be inadequately controlled with an ACE inhibitor.  or
                                                                                                         The condition must be inadequately controlled with verapamil.
C14245              P14245         CN14245          Lercanidipine with enalapril                         Hypertension
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                    Perindopril with amlodipine                          The treatment must not be for the initiation of anti-hypertensive therapy; AND
                                                                                                         The condition must be inadequately controlled with an ACE inhibitor.  or
                                                    Ramipril with felodipine                             The condition must be inadequately controlled with a dihydropyridine calcium channel blocker.

C14246              P14246         CN14246          Perindopril with amlodipine                          Stable coronary heart disease
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         The treatment must not be for the initiation of therapy for coronary heart disease; AND
                                                                                                         The condition must be stabilised by treatment with perindopril and amlodipine at the same doses.
C14251              P14251         CN14251          Bisoprolol                                           Moderate to severe heart failure
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                    Carvedilol                                           Patient must be stabilised on conventional therapy, which must include an ACE inhibitor or Angiotensin II antagonist, if tolerated.

                                                    Metoprolol succinate

                                                    Nebivolol

C14254              P14254         CN14254          Sacubitril with valsartan                            Chronic heart failure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Compliance with Authority Required procedures - Streamlined Authority Code 14254
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must be symptomatic with NYHA classes II, III or IV; AND
                                                                                                         Patient must have a documented left ventricular ejection fraction (LVEF) of less than or equal to 40%; AND
                                                                                                         Patient must receive concomitant optimal standard chronic heart failure treatment, which must include a beta-blocker, unless at least one of the following is present in relation to the beta-blocker:
                                                                                                          (i) a contraindication listed in the Product Information, (ii) an existing/expected intolerance, (iii) local treatment guidelines recommend initiation of this drug product prior to a beta-blocker; AND
                                                                                                         Patient must have been stabilised on an ACE inhibitor at the time of initiation with this drug, unless such treatment is contraindicated according to the TGA-approved Product Information or cannot be tolerated; or
                                                                                                         Patient must have been stabilised on an angiotensin II antagonist at the time of initiation with this drug, unless such treatment is contraindicated according to the TGA-approved Product Information or cannot be tolerated; AND
                                                                                                         The treatment must not be co-administered with an ACE inhibitor or an angiotensin II antagonist.
C14255              P14255         CN14255          Candesartan with hydrochlorothiazide                 Hypertension
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                    Irbesartan